Compare StocksCRM vs CVS

Salesforce, Inc. (CRM) vs CVS Health Corporation (CVS): Which Is the Better Buy in 2026?

As of 2026-08-03, CRM is undervalued at $184, with a DCF intrinsic value of $222981480055 and a margin of safety of 100%. CVS is overvalued at $104, with an intrinsic value of $29 and a margin of safety of -263%. Of the two, CRM has the wider margin of safety.

CRM
Salesforce, Inc.
$184.02
VS
CVS
CVS Health Corporation
$104.43

Rewards

CRM
  • Gross margin of 77.6% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Free cash flow has grown at a 31.6% CAGR over the past 4 years, demonstrating strong earnings power growth.
  • Each dollar of retained earnings has created $5.53 of earning power — management is an exceptional capital allocator.
CVS
  • Management has timed buybacks well — 2 out of 3 years showed value-accretive repurchases.
  • PEG ratio of 0.29 suggests the stock is undervalued relative to its growth rate — paying less than 1x for each unit of earnings growth.

Risks

CRM
  • Altman Z-Score of 0.81 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.
CVS
  • Gross margin of 13.4% is low, suggesting a competitive or commodity-like market with limited pricing power.
  • FCF yield of 5.9% suggests reasonable valuation assuming continued moderate growth.
  • Trailing P/E of 45.8x is 67% above the historical average of 27.4x — the stock trades at a premium to its own history.

Key Valuation Metrics

Learn more →
CRM
CVS
Valuation
$16.55B
Free Cash Flow
$7.81B
N/A
FCF Yield
5.86%
21.32
Trailing P/E
45.80
11.86
Forward P/E
12.40
Quality & Moat
9.61%
ROIC
8.47%
16.91%
ROE
3.75%
77.64%
Gross Margin
13.39%
0.76
PEG Ratio
0.29
Balance Sheet Safety
0.90
Net Debt / Equity
0.86
N/A
Interest Coverage
N/A
2.38
Net Debt / EBITDA
4.32
0.96%
Dividend Yield
2.55%
CRM: 6Ties: 3CVS: 2
CRMCVS

Historical Fundamentals

Learn more →
CRM

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

CVS

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
CRM
$-0.00
created per $1 retained over 3 years
Market Cap Declined
Σ Retained
$14.67B
Δ Market Cap
$-79.12
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
CVS
$-4.20
created per $1 retained over 3 years
Market Cap Declined
Σ Retained
$4.82B
Δ Market Cap
$-20.28B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
CRM
100.0% Margin of Safety
Price is 100.0% below estimated fair value
Current Price: $184.02
Fair Value: $222981480055.14
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
CVS
262.9% Overvalued
Price is 262.9% above estimated fair value
Current Price: $104.43
Fair Value: $28.78
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
CRM

What growth rate is the market pricing in at $184?

-21.2%
Market-Implied Owner Earnings Growth
Standard FCF implies -30.0%

The market implies -21.2% Owner Earnings growth, below historical trends — potential opportunity.

Standard FCF implies a more demanding -30.0%, reflecting heavy growth investment expected to generate future returns.

CVS

What growth rate is the market pricing in at $104?

+21.9%
Market-Implied Owner Earnings Growth
Standard FCF implies +11.1%

The market implies +21.9% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +11.1%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
CRM
58/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with revenue predictability as the key competitive advantage. Improving roic consistency would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
CVS
49/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with revenue predictability as the key competitive advantage. Improving roic consistency would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
CRM
-2.73
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
CVS
-2.54
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
CRM
Insiders 3.0%Institutions 93.8%Retail & Other 3.2%
No. of Institutional Holders3,568
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
CVS
Insiders 0.1%Institutions 90.3%Retail & Other 9.6%
No. of Institutional Holders2,546
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
CRM
0
Buys (3M)
4
Buys (12M)
Total value (12M): $26.52M
ALBER LAURA
Director
$500,266
@ $194.58 · 2026-03-19
KIRK DAVID BLAIR
Director
$500,178
@ $194.62 · 2026-03-18
KIRK DAVID BLAIR
Director
$500,722
@ $258.64 · 2025-12-17
MORFIT G MASON
Director and Beneficial Owner of more than 10% of a Class of Security
$25.02M
@ $260.58 · 2025-12-05
Open market purchases · includes direct & indirect ownership · excludes option exercises
CVS
0
Buys (3M)
0
Buys (12M)
SANSONE GUY P
Director
$100,009
@ $63.70 · 2025-06-05
MAHONEY MICHAEL F
Director
$2.00M
@ $66.70 · 2025-02-18
NELSON STEVEN H
Officer
$1,289
@ $53.71 · 2025-01-23
CAPOZZI HEIDI B
Officer
$4,589
@ $57.36 · 2024-10-23
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
CRM
0
Sells (3M)
15
Sells (12M)
Total value (12M): $40.30M
KROES NEELIE
Director
$929,276
@ $238.70 · 2026-01-14
HARRIS G PARKER
Officer and Director
$31.61M
@ $234.70 · 2025-12-02
BENIOFF MARC RUSSELL
Chief Executive Officer
$575,140
@ $255.62 · 2025-10-23
BENIOFF MARC RUSSELL
Chief Executive Officer
$590,102
@ $262.27 · 2025-10-21
BENIOFF MARC RUSSELL
Chief Executive Officer
$567,631
@ $252.28 · 2025-10-20
BENIOFF MARC RUSSELL
Chief Executive Officer
$550,430
@ $244.64 · 2025-10-17
BENIOFF MARC RUSSELL
Chief Executive Officer
$558,810
@ $248.36 · 2025-10-16
BENIOFF MARC RUSSELL
Chief Executive Officer
$536,322
@ $238.37 · 2025-10-15
BENIOFF MARC RUSSELL
Chief Executive Officer
$548,796
@ $243.91 · 2025-10-14
BENIOFF MARC RUSSELL
Chief Executive Officer
$1.10M
@ $244.75 · 2025-10-13
BENIOFF MARC RUSSELL
Chief Executive Officer
$547,344
@ $243.26 · 2025-10-09
BENIOFF MARC RUSSELL
Chief Executive Officer
$539,533
@ $239.79 · 2025-10-08
BENIOFF MARC RUSSELL
Chief Executive Officer
$555,001
@ $246.67 · 2025-09-23
BENIOFF MARC RUSSELL
Chief Executive Officer
$552,798
@ $245.69 · 2025-09-19
BENIOFF MARC RUSSELL
Chief Executive Officer
$545,384
@ $242.39 · 2025-09-15
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
CVS
1
Sells (3M)
1
Sells (12M)
Total value (12M): $6.23M
MANDADI TILAK
Officer
$6.23M
@ $89.58 · 2026-05-08
CLARK JAMES DAVID
Officer
$498,488
@ $66.35 · 2025-03-05
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
CRM
FearGreed
😨Fear(39/100)

"Market is pessimistic — investigate whether fears are temporary or structural"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
CVS
FearGreed
😏Greed(62/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
CRM
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Fear (39)
CVS
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (62)
View CRM Full AnalysisView CVS Full Analysis

Frequently Asked Questions: CRM vs CVS

Is Salesforce, Inc. or CVS Health Corporation more undervalued in 2026?

Based on our discounted cash flow model, CRM trades at a 100.0% margin of safety (intrinsic value $222981480055 vs. price $184), compared to CVS's -262.9% margin of safety (intrinsic $29 vs. $104).

Which stock has a wider economic moat, Salesforce, Inc. or CVS Health Corporation?

CRM scores 58/100 (Narrow moat), while CVS scores 49/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Salesforce, Inc. in financial distress?

CRM's Altman Z-Score of 0.8 places it in the Distress zone, signaling elevated bankruptcy risk. CVS scores 2.3 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, Salesforce, Inc. or CVS Health Corporation?

CRM earns 9.6% ROIC versus CVS's 8.5%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, Salesforce, Inc.'s or CVS Health Corporation's?

CRM's dividend earns a safety score of 88/100 (Very Safe), compared to CVS's 45/100 (Borderline). CRM has raised its dividend for 1 consecutive years.